팔로우
Wouter Hendrickx
Wouter Hendrickx
Sidra Medicine
sidra.org의 이메일 확인됨 - 홈페이지
제목
인용
인용
연도
NY-ESO-1 based immunotherapy of cancer: current perspectives
R Thomas, G Al-Khadairi, J Roelands, W Hendrickx, S Dermime, ...
Frontiers in immunology 9, 947, 2018
2232018
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
B Van Calster, I Vanden Bempt, M Drijkoningen, N Pochet, J Cheng, ...
Breast cancer research and treatment 113 (1), 181-187, 2009
1152009
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis
W Hendrickx, I Simeone, S Anjum, Y Mokrab, F Bertucci, P Finetti, ...
Oncoimmunology 6 (2), e1253654, 2017
1142017
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
L De Maeyer, E Van Limbergen, K De Nys, P Moerman, N Pochet, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
1142008
Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis
J Decock, JR Long, RC Laxton, XO Shu, C Hodgkinson, W Hendrickx, ...
Cancer research 67 (21), 10214-10221, 2007
1092007
Single-cell mass cytometry and transcriptome profiling reveal the impact of graphene on human immune cells
M Orecchioni, D Bedognetti, L Newman, C Fuoco, F Spada, W Hendrickx, ...
Nature communications 8 (1), 1-14, 2017
1052017
Immunogenomic classification of colorectal cancer and therapeutic implications
J Roelands, PJK Kuppen, L Vermeulen, C Maccalli, J Decock, E Wang, ...
International journal of molecular sciences 18 (10), 2229, 2017
1012017
Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis
J Decock, W Hendrickx, U Vanleeuw, V Van Belle, S Van Huffel, ...
BMC cancer 8 (1), 1-8, 2008
952008
Relationship between age and axillary lymph node involvement in women with breast cancer
H Wildiers, B Van Calster, LV van de Poll-Franse, W Hendrickx, J Røislien, ...
J Clin Oncol 27 (18), 2931-2937, 2009
872009
Cathepsin B, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer
J Decock, N Obermajer, S Vozelj, W Hendrickx, R Paridaens, J Kos
The International journal of biological markers 23 (3), 161-168, 2008
852008
Prognostic and predictive immune gene signatures in breast cancer
D Bedognetti, W Hendrickx, FM Marincola, LD Miller
Current opinion in oncology 27 (6), 433-444, 2015
722015
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessImmunogenic Subtypes of Breast Cancer
LD Miller, JA Chou, MA Black, J Chifman, A Alistar, T Putti, X Zhou, ...
Cancer immunology research 4 (7), 600-610, 2016
712016
Immune oncology, immune responsiveness and the theory of everything
T Turan, D Kannan, M Patel, J Matthew Barnes, SG Tanlimco, R Lu, ...
Journal for immunotherapy of cancer 6 (1), 1-10, 2018
522018
Germline genetic contribution to the immune landscape of cancer
RW Sayaman, M Saad, V Thorsson, D Hu, W Hendrickx, J Roelands, ...
Immunity 54 (2), 367-386. e8, 2021
442021
Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients
C Maccalli, D Giannarelli, C Chiarucci, O Cutaia, G Giacobini, ...
Oncoimmunology 6 (7), e1323618, 2017
402017
Disentangling the relationship between tumor genetic programs and immune responsiveness
D Bedognetti, W Hendrickx, M Ceccarelli, LD Miller, B Seliger
Current Opinion in Immunology 39, 150-158, 2016
392016
Pleiotropic functions of the tumor-and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice
J Decock, W Hendrickx, S Thirkettle, A Gutiérrez-Fernández, ...
Breast Cancer Research 17 (1), 1-13, 2015
382015
Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
J Roelands, W Hendrickx, G Zoppoli, R Mall, M Saad, K Halliwill, ...
Journal for immunotherapy of cancer 8 (1), 2020
372020
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas
J Decock, W Hendrickx, M Drijkoningen, H Wildiers, P Neven, A Smeets, ...
Disease markers 23 (3), 189-196, 2007
352007
The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
F Bertucci, P Finetti, I Simeone, W Hendrickx, E Wang, FM Marincola, ...
British Journal of Cancer 119 (11), 1383-1391, 2018
322018
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20